EUVIMEDEUVIMED entdecken
Crossref

Cabozantinib activates TFEB-mediated autophagy to exert anti-tumor effects in hepatocellular carcinoma

Cheng Chen, Yongjie Hu, Chenggang Zhang, Xiaocui Zhou

In Vitro Cellular & Developmental Biology - Animal · 2026-05 · 62 (5) · 661-672

DOI: 10.1007/s11626-026-01161-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vitro Cellular & Developmental Biology - Animal, online erschienen am 08.04.2026. Verfasst von Cheng Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Me…. Hauptthemen laut MEDLINE: Autophagy, Liver Neoplasms, Carcinoma, Hepatocellular, Anilides. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autophagy signaling plays a crucial yet complex role in hepatocellular carcinoma (HCC), influencing tumor progression and treatment response. Cabozantinib is an orally administered multi-kinase inhibitor used in the treatment of various advanced cancers, including renal cell carcinoma and HCC. However, its precise mechanisms of action in HCC require further elucidation. Our study first revealed elevated levels of phosphorylated TFEB (p-TFEB, Ser142) in human HCC tissues and cell lines, indicating impaired TFEB-mediated autophagic flux in hepatocellular carcinoma. Treatment with Cabozantinib induced dose-dependent cytotoxicity, oxidative stress (increased ROS and decreased GSH), and mitochondrial dysfunction (reduced Complex IV activity and ATP production). Furthermore, Cabozantinib promoted autophagy activation, as evidenced by increased autophagosome formation, elevated LC3-II/I conversion and Beclin1 expression, and decreased p62 levels. Mechanistically, Cabozantinib inhibited TFEB phosphorylation at Ser142 and enhanced its nuclear translocation. Critically, TFEB knockdown abolished Cabozantinib-induced autophagy, confirming that the pro-autophagic effects are TFEB-dependent. These findings demonstrate that Cabozantinib exerts its anti-tumor activity in HCC through activating TFEB-mediated autophagy pathway by inducing oxidative stress and mitochondrial damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyLiver NeoplasmsCarcinoma, HepatocellularAnilidesPyridinesBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsAntineoplastic AgentsHumansCell Line, TumorOxidative StressPhosphorylationMitochondriaReactive Oxygen SpeciesSignal Transduction

Stichwörter der Autor:innen

AutophagyCabozantinibHepatocellular carcinomaTFEB

Substanzen

cabozantinibAnilidesPyridinesBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsTFEB protein, humanAntineoplastic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of General Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, No. 110, Ganhe Road, Hongkou District, Shanghai, 200080, China.
  • Department of Medical Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, No. 110, Ganhe Road, Hongkou District, Shanghai, 200080, Chin…

Förderung

  • Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

Zitieren

APA

Chen, C., Hu, Y., Zhang, C., & Zhou, X. (2026). Cabozantinib activates TFEB-mediated autophagy to exert anti-tumor effects in hepatocellular carcinoma. In Vitro Cellular & Developmental Biology - Animal, 62(5), 661-672. https://doi.org/10.1007/s11626-026-01161-3

Vancouver

Chen C, Hu Y, Zhang C, Zhou X. Cabozantinib activates TFEB-mediated autophagy to exert anti-tumor effects in hepatocellular carcinoma. In Vitro Cellular & Developmental Biology - Animal. 2026;62(5):661-672. doi:10.1007/s11626-026-01161-3

BibTeX
@article{Chen2026,
  author = {Chen, Cheng and Hu, Yongjie and Zhang, Chenggang and Zhou, Xiaocui},
  title = {Cabozantinib activates TFEB-mediated autophagy to exert anti-tumor effects in hepatocellular carcinoma},
  journal = {In Vitro Cellular & Developmental Biology - Animal},
  year = {2026},
  volume = {62},
  number = {5},
  pages = {661--672},
  doi = {10.1007/s11626-026-01161-3}
}
Kostenlos starten →